Literature DB >> 28325797

Management of Atherosclerotic Cardiovascular Disease Risk Factors in the Older Adult Patient With Diabetes.

Mary T Korytkowski1, Daniel E Forman2.   

Abstract

: Older adults with diabetes are at higher risk for atherosclerotic cardiovascular disease (ASCVD) than younger adults with diabetes and older adults without diabetes. The rationale to implement ASCVD risk-lowering therapies in older adults with diabetes is compelling. Recommendations for lifestyle modification, lipid-lowering therapy, blood pressure management, blood glucose control, and aspirin therapy are often based on studies that show their efficacy in younger populations. However, the risks associated with each of these interventions increase with age, and favorable risk-to-benefit ratios demonstrated in younger adults with diabetes are less certain in older populations. The variability in health status among older adults is pertinent. Those with robust health are more likely to tolerate and derive benefit from many therapies when compared with those who have more complex health including frailty. Age- and/or frailty-stratified data to help clarify these relationships are sparse. In this Perspective, current recommendations for modifying ASCVD risk are described with a review of the pertinent literature that guides their application in older adults. A pragmatic approach to the treatment of ASCVD risk factors in older adults with diabetes is presented.
© 2017 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28325797     DOI: 10.2337/dc16-0815

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  4 in total

1.  Diabetes and Aging: Unique Considerations and Goals of Care.

Authors:  Rita R Kalyani; Sherita H Golden; William T Cefalu
Journal:  Diabetes Care       Date:  2017-04       Impact factor: 19.112

2.  Pulse pressure is more relevant than systolic and diastolic blood pressure in patients with type 2 diabetes and cardiovascular disease.

Authors:  Vlad Alexandru Buda; Dana Mihaela Ciobanu; Gabriela Roman
Journal:  Clujul Med       Date:  2018-10-30

3.  Survey of Current Management Practices for Carotid Webs.

Authors:  Kyle Wojcik; James Milburn; Gabriel Vidal; Joseph Tarsia; Andrew Steven
Journal:  Ochsner J       Date:  2019

4.  Efficacy and safety of dulaglutide 3.0 and 4.5 mg in patients aged younger than 65 and 65 years or older: Post hoc analysis of the AWARD-11 trial.

Authors:  Juan P Frias; Enzo Bonora; Luis Nevárez Ruiz; Stanley H Hsia; Heike Jung; Sohini Raha; David A Cox; M Angelyn Bethel; Manige Konig
Journal:  Diabetes Obes Metab       Date:  2021-07-08       Impact factor: 6.577

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.